At a Glance
Therapeutic Area:
Approved Applications:
Cubicin® is a lipopeptide antibiotic for Gram-positive infections, particularly Staph and MRSA infections and the following infections:
 Complicated skin and skin structure infections (cSSSI) caused by susceptible isolates of the following Gram-positive bacteria: Staphylococcus aureus (including methicillin-resistant isolates), Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus dysgalactiae subspecies equisimilis, and Enterococcus faecalis (vancomycin-susceptible isolates only). S. aureus are bloodstream infections (bacteremia), including those with right-sided infective endocarditis, caused by methicillin-susceptible and methicillin-resistant isolates.
Applications In Development:
Acquisition Date:
March 2011
Royalty Seller:


© 2014 Royalty Pharma, RP Management LLC. All Rights Reserved.